Genentech Newswire

Comprehensive Real-Time News Feed for Genentech.

Results 1 - 20 of 392 in Genentech

  1. Dalradian Closes C$27 Million FinancingsRead the original story

    Sep 6, 2012 | Canada NewsWire

    The Offering was conducted through a syndicate of underwriters led by Canaccord Genuity Corp. and including Cormark Securities Inc., BMO Capital Markets, Beacon Securities Limited, Dundee Securities Ltd., Jennings Capital Inc. and National Bank Financial Inc. .

    Comment?

  2. GRAMMYA Award-Winning Singer Jennifer Hudson Lends Her Voice To...Read the original story

    Wednesday | Freshnews

    LOS ANGELES and NEW YORK, July 30, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer , a program of the Entertainment Industry Foundation, and Genentech, one of the world's leading biotech companies, have joined forces with GRAMMY -winning singer, Oscar -winning actress, and SU2C Ambassador Jennifer Hudson for their latest campaign, entitled: "Two ... (more)

    Comment?

  3. B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2014Read the original story

    Tuesday Jul 29 | SBWire

    ... Mentioned Bristol-Myers Squibb Company Boehringer Ingelheim GmbH Amgen Inc. Sanofi Seattle Genetics, Inc. Genentech, Inc. MedImmune, LLC Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Biocon Limited Ono Pharmaceutical Co., Ltd. Sandoz Inc. ...

    Comment?

  4. Google X Collecting Genetic Data for 'Baseline' Health ProjectRead the original story

    Friday Jul 25 | PC Magazine

    ... how technology can positively affect aging and associated diseases. Arthur D. Levinson, chairman and former CEO of Genentech and chairman of Apple, is Calico's CEO and a founding investor. Chloe Albanesius has been with PCMag.com since April 2007, ...

    Comment?

  5. Google takes on the human body to find out what a healthy person looks likeRead the original story w/Photo

    Friday Jul 25 | VentureBeat

    ... last September and includes major genetic research players like Hal Barron, a former chief medical officer at Genentech. Baseline is extremely broad in scope and Google wants to expand the study to include thousands of people - which raises ...

    Comment?

  6. Genomics startup allies with IlluminaRead the original story w/Photo

    Thursday Jul 24 | The San Diego Union-Tribune

    ... DNA sequencing giant Illumina and brought on board some prominent industry veterans. Herbert Boyer, a cofounder of Genentech; Henry Nordhoff, former chief executive of Gen-Probe; and Andrew von Eschenbach, a former commissioner of the U.S. Food and ...

    Comment?

  7. Swiss drug maker Roche posts 7 percent profit dropRead the original story w/Photo

    Thursday Jul 24 | Washington Examiner

    ... Perjeta and Kadcyla, and by its diagnostics products. This month, Roche said its U.S.-based biotech company Genentech had agreed to acquire American biotechnology firm Seragon Pharmaceuticals, Inc. for up to $1.73 billion in cash and contingency ...

    Comment?

  8. Community Impact: bringing students face to face with the world's top scientistsRead the original story w/Photo

    Thursday Jul 24 | Business Journal

    What better way to get students interested in science than to bring them into one of the top biotechs in the world? Genentech's Gene Academy shuttles students from three South San Francisco elementary schools and one middle school to the Genentech campus once a week for help with homework and projects as well as to talk with scientists at their ... (more)

    Comment?

  9. Advanced Biological Laboratories (ABL) and Roche Diagnostics...Read the original story

    Thursday Jul 24 | Business Wire

    ... 85,000 people worldwide, invested 8.7 billion Swiss francs in R&D and posted sales of 46.8 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai ...

    Comment?

  10. Cypher Genomics Appoints to the Board of Directors, Henry Nordhoff as ...Read the original story

    Thursday Jul 24 | Freshnews

    ... board of directors. In addition, Cypher appointed as directors: Herbert Boyer, Ph.D. , who co-founded and led Genentech as vice president, and Andrew von Eschenbach, M.D. , who was the former commissioner of the U.S. Food and Drug Administration ...

    Comment?

  11. Roche Profit Dented by CurrenciesRead the original story w/Photo

    Wednesday Jul 23 | Wall Street Journal

    Roche Holding AG reported Thursday that first-half net profit slid 7% under pressure from exchange rates, but strong sales of its cancer therapies prompted the Swiss drug giant to confirm its outlook for the full year.

    Comment?

  12. Roche Profit Falls on Franc Strengthl New-Drug Sales RiseRead the original story

    Wednesday Jul 23 | Bloomberg

    Roche Holding AG 's first-half profit fell 7 percent as the strength of the Swiss franc offset rising sales of the drugmaker's new cancer medicines.

    Comment?

  13. Ottawa cancer lab part of 'stepping into this future,' newly recruited director saysRead the original story w/Photo

    Tuesday Jul 22 | Ottawa Citizen

    ... he has trained at Toronto's Hospital for Sick Children, then at Yale University, and recently worked at Genentech Inc. in California. "It's of course really exciting to be a part of something brand new. This lab is going to be put together from the ...

    Comment?

  14. Asthma drug may help those with chronic hivesRead the original story w/Photo

    Tuesday Jul 22 | WJRT

    ... for more than six weeks," explained study senior author Dr. Karin Rosen, an associate group medical director with Genentech Inc., in San Francisco. "That's usually just .5 to 1 percent of hives patients." "But for those patients, this is a really ...

    Comment?

  15. New Market Study, "Follicular Lymphoma - Pipeline Review, H2 2014", Has Been PublishedRead the original story

    Tuesday Jul 22 | SBWire

    ... Company, Johnson & Johnson, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Amgen Inc., GlaxoSmithKline plc, Genentech, Inc., MedImmune, LLC, Gilead Sciences, Inc., Merck & Co., Inc., Infinity Pharmaceuticals, Inc., Celltrion, Inc., Millennium ...

    Comment?

  16. Donaco International Limited (ASX:DNA) On-Market Buy-Back and Appendix 3CRead the original story

    Monday Jul 21 | Hispanic Business

    The buy-back is being undertaken as part of the Company's ongoing capital management program.

    Comment?

  17. Asthma Drug Found Effective Against Chronic HivesRead the original story

    Monday Jul 21 | News Max

    ... for more than six weeks," explained study senior author Dr. Karin Rosen, an associate group medical director with Genentech Inc., in San Francisco. "That's usually just .5 to 1 percent of hives patients." "But for those patients, this is a really ...

    Comment?

  18. Genentech Alzheimer's drug misses goals in studiesRead the original story

    Friday Jul 18 | WTVF Nashville

    An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.

    Comment?

  19. Now Available: Allergic Asthma - Pipeline Review, H1 2014Read the original story

    Friday Jul 18 | SBWire

    ... drove them from pipeline Companies Mentioned in this Report: Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Genentech, Inc., BioTech Tools, Dainippon Sumitomo Pharma Co., Ltd., Infinity Pharmaceuticals, Inc., Novartis AG, ALK-Abello A/S, DBV ...

    Comment?

  20. Genentech Alzheimer's drug misses study goals but shows some promise in milder diseaseRead the original story w/Photo

    Thursday Jul 17 | Canada.com

    ... of a brain damaged by advanced Alzheimer's disease. Researchers said an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease. An experimental ...

    Comment?